Tumor infiltrating lymphocytes: current pathways to a standard biomarker in breast cancer

Expert Rev Anticancer Ther. 2021 Dec;21(12):1299-1301. doi: 10.1080/14737140.2021.1953987. Epub 2021 Jul 24.

Authors

William T Tran^{1

2}, Fang-I Lu³, Roberto Salgado^{4

5}

Affiliations

¹ Department of Radiation Oncology, Sunnybrook Health Sciences Centre, Toronto, Canada.
² Department of Radiation Oncology, University of Toronto, Toronto, Canada.
³ Pathobiology and Laboratory Medicine, University of Toronto, Toronto, Canada.
⁴ Department of Pathology, GZA-ZNA Hospitals, Antwerp, Belgium.
⁵ Division of Research, Peter Mac Callum Cancer Centre, Melbourne, Australia.

PMID: 34236013
DOI: 10.1080/14737140.2021.1953987

No abstract available

Keywords: Tumor-infiltrating lymphocytes; biomarkers; breast cancer; tumor immune microenvironment.

Publication types

Editorial
Research Support, Non-U.S. Gov't

MeSH terms

Biomarkers, Tumor / metabolism
Breast Neoplasms* / pathology
Female
Humans
Lymphocytes, Tumor-Infiltrating* / metabolism
Lymphocytes, Tumor-Infiltrating* / pathology
Prognosis
Tumor Microenvironment

Substances

Biomarkers, Tumor